Skip to content

Use of Injectable-platelet-rich-fibrin (I-PRF) to Thicken Gingival Phenotype

New Approach to Increasing Gingival Thickness in Individuals With Fine Gingival Phenotype:Injectable Platelet Rich Fibrin (I-PRF)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03274674
Enrollment
29
Registered
2017-09-07
Start date
2017-04-04
Completion date
2018-06-01
Last updated
2020-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontoclasia, Gingiva; Injury, Condition, Blood Clot, Gingiva Disorder

Keywords

PRF, I-PRF, Microneedle, Gingival Thickness, Injectable-Platelet-Rich-Fibrin, Platelet Rich Fibrin

Brief summary

The main objective of this study is to investigate whether the for individuals with thin gingival thickness who are susceptible to gingival recession, the investigators will use i-PRF with microneedle to increase gingival thickness without the need for surgical procedures

Detailed description

Due to the thin gingival phenotype, gingival recession is a problem. The investigators aimed to increase the gingival thickness using i-PRF with microneedle without considering surgical procedures, considering the positive effects of platelet concentrations on revascularization and wound healing in individuals with bone defect, fenestration and gingival thickness which are prone to gingival recession .

Interventions

OTHERI-PRF

Venous blood will be taken from the patient every session and I-PRF will be created in the centrifuge.I-PRF injected on one side of bilateral thin gingival thickness.Microneedle application plus I-PRF injected on the other side in patients with bilateral region with thin gingival phenotype.Apply once a week and one month after the end of the injections, the patient will be called to the control.

Sponsors

Bezmialem Vakif University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

Blinded, Parallel group, Randomized Controlled Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Never smokers * Had no history of systemic disease * Aged ≥18 years old

Exclusion criteria

* Patients with a history of diabetes mellitus or systemic disease * Patients who were under any medication that was known to influence periodontal tissues * Patients with hormonal changes such as pregnancy or lactation * Toothless individuals * Patients who were clotting disorders

Design outcomes

Primary

MeasureTime frameDescription
Gingival thickness (mm)2 monthsChange in clinical measures of gingival thickness

Secondary

MeasureTime frameDescription
Plaque Index (PI)2 monthsChange in clinical measures of gingival parameters
Gingival Index (GI)2 monthsChange in clinical measures of gingival parameters
Bleeding on probing (BOP)2 monthsChange in clinical measures of gingival parameters
Clinical attachment level (CAL)2 monthsChange in clinical measures of gingival parameters
Probing pocket depth (PD)2 monthsChange in clinical measures of gingival parameters

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026